Inflammation

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes